Minimum P value for the association of selected genes and surrounding regions with VTE
Group . | Gene . | Encoded protein . | No. of variants . | No. of variants exceeding threshold . | Position (Chr:marker:alleles) . | Freq . | β . | Std Err . | Minimum P value . |
---|---|---|---|---|---|---|---|---|---|
Pos | F2 | Prothrombin | 498 | 66 | 11:46761055:G:A | 0.014 | 0.676 | 0.024 | 1.01E-175 |
Pos | F5 | Factor V | 1179 | 279 | 1:169519049:C:T | 0.026 | 1.090 | 0.016 | <1.00E-300 |
Pos | FGG | Fibrinogen γ-chain | 527 | 136 | 4:155525695:G:A | 0.256 | 0.204 | 0.006 | 2.86E-242 |
Pos | PROC | Protein C | 749 | 141 | 2:128140500:G:T | 0.670 | −0.070 | 0.006 | 5.68E-33 |
Pos | SERPINC1 | Antithrombin | 594 | 24 | 1:173882980:G:A | 0.137 | −0.049 | 0.009 | 9.59E-09 |
Neg | KRT14 | Keratin 14 | 626 | 0 | 17:39763940:T:C | 0.981 | −0.391 | 0.132 | 2.98E-03 |
Neg | MC1R | Melanocortin 1 receptor | 904 | 0 | 16:90027806:C:T | 0.022 | 0.109 | 0.031 | 3.91E-04 |
Neg | NGF | Nerve growth factor | 1106 | 0 | 1:115902240:C:T | 0.180 | 0.033 | 0.008 | 1.78E-05 |
Neg | PRX | Periaxin | 737 | 0 | 19:40932707:C:T | 0.015 | 0.304 | 0.100 | 2.45E-03 |
Neg | TGM5 | Transglutaminase 5 | 515 | 1 | 15:43580645:C:T | 0.039 | −0.082 | 0.016 | 4.84E-07 |
Hyp | CPB2 | TAFI | 948 | 0 | 13:46716076:C:T | 0.790 | −0.027 | 0.007 | 1.83E-04 |
Hyp | PLAT | tPA | 755 | 0 | 8:42055986:C:T | 0.074 | −0.057 | 0.012 | 4.70E-06 |
Hyp | PLAU | uPA | 606 | 0 | 10:75673101:C:T | 0.254 | 0.027 | 0.007 | 4.86E-05 |
Hyp | PLAUR | uPAR | 928 | 0 | 19:44109067:G:A | 0.047 | 0.054 | 0.018 | 2.75E-03 |
Hyp | PLG | Plasminogen | 1249 | 0 | 6:161152905:C:T | 0.013 | 0.103 | 0.028 | 2.60E-04 |
Hyp | SERPINB2 | PAI-2 | 974 | 0 | 18:61493352:C:T | 0.046 | 0.104 | 0.041 | 1.07E-02 |
Hyp | SERPINE1 | PAI-1 | 922 | 0 | 7:100746344:C:T | 0.149 | 0.033 | 0.008 | 3.91E-05 |
Hyp | SERPINF2 | α2-antiplasmin | 871 | 1 | 17:1639350:C:T | 0.031 | 0.082 | 0.018 | 3.00E-06 |
Group . | Gene . | Encoded protein . | No. of variants . | No. of variants exceeding threshold . | Position (Chr:marker:alleles) . | Freq . | β . | Std Err . | Minimum P value . |
---|---|---|---|---|---|---|---|---|---|
Pos | F2 | Prothrombin | 498 | 66 | 11:46761055:G:A | 0.014 | 0.676 | 0.024 | 1.01E-175 |
Pos | F5 | Factor V | 1179 | 279 | 1:169519049:C:T | 0.026 | 1.090 | 0.016 | <1.00E-300 |
Pos | FGG | Fibrinogen γ-chain | 527 | 136 | 4:155525695:G:A | 0.256 | 0.204 | 0.006 | 2.86E-242 |
Pos | PROC | Protein C | 749 | 141 | 2:128140500:G:T | 0.670 | −0.070 | 0.006 | 5.68E-33 |
Pos | SERPINC1 | Antithrombin | 594 | 24 | 1:173882980:G:A | 0.137 | −0.049 | 0.009 | 9.59E-09 |
Neg | KRT14 | Keratin 14 | 626 | 0 | 17:39763940:T:C | 0.981 | −0.391 | 0.132 | 2.98E-03 |
Neg | MC1R | Melanocortin 1 receptor | 904 | 0 | 16:90027806:C:T | 0.022 | 0.109 | 0.031 | 3.91E-04 |
Neg | NGF | Nerve growth factor | 1106 | 0 | 1:115902240:C:T | 0.180 | 0.033 | 0.008 | 1.78E-05 |
Neg | PRX | Periaxin | 737 | 0 | 19:40932707:C:T | 0.015 | 0.304 | 0.100 | 2.45E-03 |
Neg | TGM5 | Transglutaminase 5 | 515 | 1 | 15:43580645:C:T | 0.039 | −0.082 | 0.016 | 4.84E-07 |
Hyp | CPB2 | TAFI | 948 | 0 | 13:46716076:C:T | 0.790 | −0.027 | 0.007 | 1.83E-04 |
Hyp | PLAT | tPA | 755 | 0 | 8:42055986:C:T | 0.074 | −0.057 | 0.012 | 4.70E-06 |
Hyp | PLAU | uPA | 606 | 0 | 10:75673101:C:T | 0.254 | 0.027 | 0.007 | 4.86E-05 |
Hyp | PLAUR | uPAR | 928 | 0 | 19:44109067:G:A | 0.047 | 0.054 | 0.018 | 2.75E-03 |
Hyp | PLG | Plasminogen | 1249 | 0 | 6:161152905:C:T | 0.013 | 0.103 | 0.028 | 2.60E-04 |
Hyp | SERPINB2 | PAI-2 | 974 | 0 | 18:61493352:C:T | 0.046 | 0.104 | 0.041 | 1.07E-02 |
Hyp | SERPINE1 | PAI-1 | 922 | 0 | 7:100746344:C:T | 0.149 | 0.033 | 0.008 | 3.91E-05 |
Hyp | SERPINF2 | α2-antiplasmin | 871 | 1 | 17:1639350:C:T | 0.031 | 0.082 | 0.018 | 3.00E-06 |
Chr, chromosome; Freq, frequency; Hyp, hypothesis-based genes; Neg, negative control; PAI, plasminogen activator inhibitor; Pos, positive control; Std Err, standard error; TAFI, thrombin activatable fibrinolysis inhibitor; tPA, tissue plasminogen activator; uPA, urokinase plasminogen activator; uPAR, urokinase plasminogen activator receptor.
Significance was determined using a Bonferroni-corrected P value (P < 3.4 × 10–6, .05/14 688 variants tested)